What We Do
Brio provides manufacturer-direct access to quality-driven products, independent testing solutions, 503B medications, APIs, TRT products, peptides, and emerging longevity technologies — supporting the entire commercial pathway from product strategy through provider adoption.
Direct sourcing and product commercialization for manufacturers entering or scaling in the longevity market.
Institutional-grade supply solutions for clinics, platforms, and health systems requiring 503B-sourced medications.
Qualified active pharmaceutical ingredient access with full documentation and supply chain transparency.
Compliant, channel-appropriate distribution for peptides and emerging longevity products across multiple regulatory contexts.
Independent analytical testing through qualified laboratory partners — ensuring product integrity before it reaches the market.
Connecting qualified products to the clinic networks, pharmacy platforms, and ordering infrastructure that move them into practice.
Full-service commercial execution — from market access strategy through CRM, outbound campaigns, and account growth.
Future white-label, co-developed, and Brio-owned longevity products with recurring margin and strategic upside for ecosystem partners.
Tell us where you fit and what you're trying to build.
Join the Ecosystem